Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

FDA approve Lilly-Incyte’s treatment for hospitalised COVID patients

May 12, 2022 Business Services

The FDA has granted approval for Eli Lilly and Incyte’s Olumiant (baricitinib) to treat COVID-19 in adult patients admitted to …
News

First regenerative cell therapy for hearing loss

May 5, 2022 Business Services

Rinri Therapeutics have announced the MHRA has awarded an innovation passport to the company’s lead candidate, Rincell-1. Rincell-1 is a …
News

Nearly three million people receive lifesaving NHS cancer checks

May 5, 2022 Business Services

A record three million people received vital NHS cancer tests from March 2021 to February 2022, compared to 2.4 million …
News

Health experts report more symptoms of long COVID-19

May 5, 2022 Business Services

According to health experts, many COVID-19 patients are still suffering the effects of the condition months after they first started …
News

FDA approval for first in vitro diagnostic for early Alzheimer’s detection

May 5, 2022 Business Services

The US FDA has approved the first in vitro diagnostic to aid in the early detection of Alzheimer’s disease (AD). …
News

OMass Therapeutics raises $100 million to progress immunology and rare diseases drug pipeline

April 28, 2022 Business Services

OMass Therapeutics have announced the $100 million (£75.5 million) Series B financing to progress its drug pipeline in immunology and …
News
fdaoutsideweb

NOCIRA announces breakthrough device designation by FDA for migraine treatment

April 28, 2022 Business Services

NOCIRA is the first company to announce the FDA’s Breakthrough Device designation for the treatment of migraine attacks in both …
News

NIHR-supported trial reveals vaccine boosters maintain immunity three months on

April 21, 2022 Business Services

Latest results form the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses …
News

FDA’s Cancer Advisory Committee to evaluate safety of P13K inhibitors

April 21, 2022 Business Services

The FDA’s Oncologic Drugs Advisory Committee is holding a meeting today to discuss safety findings across the entire class of …
News

PacBio and Children’s Mercy Kansas City expand collaboration in rare disease

April 21, 2022 Business Services

PacBio has announced an expanded research collaboration with Children’s Mercy Kansas City, to use the multi-omics capabilities of PacBio’s Sequel …
News

New Programme to tackle health disparities and inequalities for women with heart failure

April 21, 2022 Business Services

Women diagnosed with heart failure have worse outcomes compared to men, in spite of a similar prevalence of the chronic …
News

Kintor’s antiviral shows protection in mild-to-moderate COVID-19

April 7, 2022 Business Services

Kintor Pharmaceutical, based in Suzhou, China, has announced top-line results from its Phase III MRCT trial of proxalutamide in outpatients …
News

Blood clot risk higher for six months after having COVID-19

April 7, 2022 Business Services

A study from Sweden suggests that after a COVID-19 infection, there is an increased risk of developing a serious blood …
News

Eligible patients in the UK granted early access for radioligand therapy in advanced prostate cancer

April 7, 2022 Business Services

Advanced Accelerator Applications (AAA), a Novartis company, has announced that eligible patients in the UK have been granted early access …
News

Global Paediatric Drug Development Centre of Excellence opened in Dublin’s North Dock

April 7, 2022 Business Services

Gilead Sciences announced on April 6th the formal opening of its Dublin city centre office, focused on developing new paediatric …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025